ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Amgen: 84% Of Micromet Shares Have Been Tendered

DOW JONES NEWSWIRES Amgen Inc. (AMGN) said nearly 84% of the shares of biotechnology company Micromet Inc. (MITI) have been tendered to its $1.16 billion takeover offer, meeting all the conditions for the acquisition to close. As of the offering's expiration Thursday, about 80 million Micromet shares had been tendered and not withdrawn. An added 3.15 million shares have been tendered by guaranteed delivery. A subsequent offering period is scheduled to expire at 12:00 a.m. EST, at the end of March 6. Amgen launched its bid to acquire Micromet in January with an aim to strengthen Amgen's cancer-drug research pipeline. A Delaware judge declined to block Amgen's purchase of Micromet, the Associated Press reported Thursday. A group of Micromet shareholders had argued that Micromet didn't try hard enough to get a better offer, and sought a preliminary injunction. The judge found that the shareholders didn't show a reasonable likelihood that they would successfully prove their claims, the AP reported. Amgen shares closed at $67.59 Thursday and were inactive premarket. The stock is up 32% in the past 12 months. -By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
05/27/201607:21:00Amgen Receives Positive CHMP Opinion To Extend Indication Of...
05/26/201616:00:00Kyprolis® (Carfilzomib) Demonstrates Economic Value In Relapsed...
05/26/201606:10:34Current Report Filing (8-k)
05/25/201619:08:00Amgen Announces Early Tender Results Of Senior Notes Exchange...
05/25/201616:09:00Amgen Announces Pricing Terms Of Senior Notes Exchange Offers
05/23/201616:40:00Samsung Targets U.S. Drug Market With Remicade Knockoff
05/19/201618:02:00Amgen Announces Voting Results of Annual Meeting of Stockholders
05/19/201616:34:00Amgen Highlights Data To Be Presented At 21st Congress Of The...
05/18/201617:44:00Amgen Researchers Discover Gene Associated With Lower Risk of...
05/18/201617:06:00Bayer to Showcase Latest Oncology Research at ASCO 2016
05/18/201617:05:00Amgen Data To Be Presented At ASCO 2016 Demonstrates More Insights...
05/18/201617:00:00Landmark deCODE genetics Study Points to a New Mechanism that...
05/17/201616:00:00Amgen's Breakaway from Cancer® Public Service Announcement Delivers...
05/13/201606:16:35Current Report Filing (8-k)
05/12/201621:14:00Amgen Commences Exchange Offers for Certain Series of Outstanding...
05/12/201603:03:00Theranos Executive to Exit Amid Probes -- WSJ
05/11/201623:10:00Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes
05/11/201622:15:00Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes
05/11/201622:10:00Theranos Executive Sunny Balwani to Depart
05/11/201621:49:00Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad